BPC 157 Balances Angiogenesis and Nitric Oxide for Healing and Protection
Reply to Sikiric et al. BPC 157 Therapy: Targeting Angiogenesis and Nitric Oxide's Cytotoxic and Damaging Actions, but Maintaining, Promoting, or Recovering Their Essential Protective Functions. Comment on "Józwiak et al. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.
Background
The peptide BPC 157 is widely recognized for its broad therapeutic potential, including roles in wound healing, gastrointestinal protection, and anti-inflammatory effects. However, the precise mechanisms by which BPC 157 exerts these diverse actions, particularly its complex interplay with angiogenesis (new blood vessel formation) and nitric oxide (NO) systems, remain a subject of ongoing scientific discussion. This reply addresses the specific question of how BPC 157 selectively modulates the beneficial and detrimental aspects of angiogenesis and NO to promote tissue repair and protection.
TitrateLab articles covering BPC-157
Written by TitrateLab, separately from the study summarized above.
